United States · Funded startup

Who invested in Ctrl-Labs

One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$28Mraised across 1 round since 2019, from 1 source

Latest round
Round, $28MFeb 2019
Investors
6
See who backed them

The rounds

  1. Feb 2019
    Round$28M

    Reported by VentureBeat

The exit

ExitBuyerPriceWhen
AcquiredFacebookundisclosedSept 2019

From historical deal records. Wrong? Tell us.

Everyone who backed them

Lux CapitalVC firm1round
MatrixHedge fund1round
Breyer CapitalPrivate equity1round
SparkGrowth equity1round
FuelAccelerator1round
GV/ Alexa Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Ctrl-Labs as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Spark CapitalVC firmPer its own site
Todd DagresVC firmPer its own site

Quick answers about Ctrl-Labs

Who invested in Ctrl-Labs?

Ctrl-Labs's investors include Lux Capital, Matrix, Breyer Capital, Spark and Fuel, and 1 more on record.

How much has Ctrl-Labs raised?

Ctrl-Labs has raised $28M across 1 round since 2019.

When did Ctrl-Labs last raise?

Ctrl-Labs's most recent round was an Undisclosed round of $28M in Feb 2019.

What was Ctrl-Labs's biggest round?

Its most recent round, $28M in Feb 2019, is also its largest on record.

Who backed Ctrl-Labs first?

Ctrl-Labs's first round on record, in Feb 2019, was backed by Lux Capital, Matrix and Breyer Capital and 3 others.

What stage is Ctrl-Labs at?

Ctrl-Labs's latest named round is an Undisclosed round, in Feb 2019.

Where is Ctrl-Labs based?

Ctrl-Labs is based in the United States.

Companies like Ctrl-Labs

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.